Coburn Brian W, Bendlin Kayli A, Sayles Harlan, Hentzen Kathryn S, Hrdy Michaela M, Mikuls Ted R
Veterans Affairs Nebraska, Western Iowa Health Care System, and University of Nebraska Medical Center, Omaha, Nebraska.
Veterans Affairs Nebraska, Western Iowa Health Care System, Omaha, Nebraska.
Arthritis Care Res (Hoboken). 2016 Jul;68(7):1028-35. doi: 10.1002/acr.22785.
To examine gout patients' knowledge of their condition, including the central role of achieving and maintaining the serum urate (SU) goal with the use of urate-lowering therapy (ULT).
This study of 612 gout patients was conducted at a Veterans Affairs medical center. Gout patients were included based on administrative diagnostic codes and receipt of at least 1 allopurinol prescription over a 1-year period. Questionnaires were mailed to patients and linked to medical records data. The questionnaire included gout-specific knowledge questions, the Patient Activation Measure, and self-reported health outcomes. Knowledge was assessed descriptively. Multivariable logistic regression was used to determine predictors of SU goal knowledge. Associations of knowledge with health outcomes were examined in exploratory analyses.
The questionnaire had a 62% response rate. Only 14% of patients knew their SU goal, while the majority answered correctly for the other 5 gout-specific knowledge questions. In adjusted analyses, having a rheumatologist as initial prescriber (odds ratio [OR] 3.0 [95% confidence interval (95% CI) 1.4-6.2]) and knowing all of the other 5 gout-specific knowledge questions (OR 2.1 [95% CI 1.3-3.4]) were associated with greater odds of knowing the SU goal. SU goal knowledge was associated with self-reported global health status, but not with self-reported health-related quality of life or gout-specific health status.
There is a knowledge deficit regarding the SU treatment goal among gout patients receiving ULT, despite generally high levels of other gout-specific knowledge. SU goal information may be an important and underutilized concept among providers treating gout patients.
探讨痛风患者对自身病情的了解程度,包括通过降尿酸治疗(ULT)实现并维持血清尿酸(SU)目标的核心作用。
本研究在一家退伍军人事务医疗中心对612例痛风患者进行。根据行政诊断代码以及在1年期间至少开具1次别嘌醇处方来纳入痛风患者。向患者邮寄问卷,并与病历数据相关联。问卷包括痛风相关知识问题、患者激活量表以及自我报告的健康结局。对知识进行描述性评估。采用多变量逻辑回归确定SU目标知识的预测因素。在探索性分析中研究知识与健康结局的关联。
问卷回复率为62%。只有14%的患者知道自己的SU目标,而对于其他5个痛风相关知识问题,大多数患者回答正确。在调整分析中,初始处方医生为风湿病专家(比值比[OR] 3.0 [95%置信区间(95%CI)1.4 - 6.2])以及知道其他所有5个痛风相关知识问题(OR 2.1 [95%CI 1.3 - 3.4])与知道SU目标的几率更高相关。SU目标知识与自我报告的总体健康状况相关,但与自我报告的健康相关生活质量或痛风特异性健康状况无关。
接受ULT的痛风患者对SU治疗目标存在知识欠缺,尽管他们对其他痛风相关知识的了解程度普遍较高。SU目标信息可能是治疗痛风患者的医疗服务提供者中一个重要但未得到充分利用的概念。